| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.007 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.007 |